Close Menu

NEW YORK – Royal Philips and Danaher's Leica Biosystems both announced this week that they have received enforcement discretion from the US Food and Drug Administration allowing pathologists to use their technology to work remotely during the coronavirus pandemic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.